Just Healthcare

Just Healthcare

Multiple Sclerosis CAR T Therapy Moves Toward Immune Reset

Early human studies suggest CAR T-cell therapy may one day help selected people with multiple sclerosis and other autoimmune diseases

Naveen Sankar S's avatar
Naveen Sankar S
May 30, 2026
∙ Paid

CAR T-cell therapy, first developed for blood cancers, is now being tested in autoimmune diseases such as multiple sclerosis, lupus, stiff person syndrome, and myasthenia gravis. The most important idea is simple: instead of only suppressing inflammation again and again, researchers are testing whether engineered immune cells can remove the immune cells…

User's avatar

Continue reading this post for free, courtesy of Naveen Sankar S.

Or purchase a paid subscription.
© 2026 Just Healthcare · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture